Apoptosis Resistant E3 Ubiquitin Protein Ligase 1 (AREL1) (Middle Region) Peptide
AREL1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all AREL1 products
- AREL1 (Apoptosis Resistant E3 Ubiquitin Protein Ligase 1 (AREL1))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-KIAA0317 antibody (Catalog #: ARP44875_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- AREL1 (Apoptosis Resistant E3 Ubiquitin Protein Ligase 1 (AREL1))
- Synonyms
- KIAA0317 Peptide, apoptosis resistant E3 ubiquitin protein ligase 1 Peptide, AREL1 Peptide
- Background
-
KIAA0317 contains 1 filamin repeat and 1 HECT (E6AP-type E3 ubiquitin-protein ligase) domain. The exact function of KIAA0317 remains unknown.
Alias Symbols: KIAA0317,
Protein Size: 823 - Molecular Weight
- 94 kDa
- Gene ID
- 9870
- NCBI Accession
- NM_001039479, NP_001034568
- UniProt
- O15033
-
You are here:
